Table 2.
The associations of FSH and blood lead levels with bone mineral density※.
| Models | Total femur bone mineral density | Lumbar spine bone mineral density | ||||
|---|---|---|---|---|---|---|
| β | 95% CI | P | β | 95% CI | P | |
| Model 1 | ||||||
| FSH | -0.0008 | -0.0010~ -0.0006 | < 0.001 | -0.0009 | -0.0012~ -0.0006 | < 0.001 |
| Model 2 | ||||||
| Blood lead levels | -0.0364 | -0.0810~ 0.0082 | 0.110 | -0.0945 | -0.2233~ 0.0342 | 0.150 |
| Model 3 | ||||||
| FSH | -0.0008 | -0.0010~ -0.0006 | < 0.001 | -0.0009 | -0.0012~ -0.0006 | < 0.001 |
| Blood lead levels | -0.0075 | -0.0523~ 0.0373 | 0.742 | 0.0013 | -0.1306~ 0.1331 | 0.985 |
FSH, follicle-stimulating hormone.
※In all models, age, BMI, race, current smoking, current alcohol consumption, education levels, marital status, annual household income, history of hypertension, diabetes, and fractures, ever been pregnant, had at least one ovary removed, use of hormone therapy, and ever treated for osteoporosis were adjusted.